Study guide

6.2 Acute Kidney Injury, Rhabdomyolysis / Myoglobinuria, and Fluid-Electrolyte Shifts

Certified Burn Registered Nurse CBRN

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Foundations of Burn Care

1.1 CBRN Exam Format, Eligibility, and BCEN Testing Standards 1.2 Anatomy, Histology, and Barrier Functions of the Skin 1.3 Burn Depth Classification and Jackson's Thermal Wound Zones

2 Chapter 2: Pathophysiology of Burn Injury & Systemic Response

2.1 Cellular Pathophysiology and Capillary Permeability in Burn Shock 2.2 Systemic Inflammatory Response Syndrome (SIRS) and MODS 2.3 Pathophysiology of Supraglottic, Subglottic, and Inhalational Injury 2.4 Cellular Phases of Burn Wound Healing and Scar Pathobiology

3 Chapter 3: Prehospital Triage, Primary Survey & Transfer Criteria

3.1 Initial Assessment, Primary Survey (ABCDEF), and Field Stabilization 3.2 Total Body Surface Area (TBSA) Calculation: Rule of Nines, Lund-Browder, and Palmar Method 3.3 American Burn Association (ABA) Burn Center Referral Criteria and Transport Logistics

4 Chapter 4: Fluid Resuscitation & Hemodynamic Stabilization (<72 Hours)

4.1 Fluid Resuscitation Formulas: Parkland (Baxter), Modified Brooke, and Consensus Protocols 4.2 Resuscitation Endpoints: Urine Output Titration, Base Deficit, and Hemodynamic Monitoring 4.3 Complications of Fluid Creep and Intra-Abdominal Hypertension / Abdominal Compartment Syndrome 4.4 Extremity Compartment Syndrome, Monitoring, and Emergent Escharotomy / Fasciotomy

5 Chapter 5: Airway Management & Inhalation Injury Management

5.1 Upper Airway Compromise, Indications for Early Endotracheal Intubation, and Airway Stabilization 5.2 Lower Airway Chemical Tracheobronchitis, Diagnostic Bronchoscopy, and Lung-Protective Mechanical Ventilation 5.3 Carbon Monoxide (CO) Toxicity, Cyanide Poisoning, and Specific Antidotes (Hydroxocobalamin)

6 Chapter 6: Acute Multisystem Assessment & Critical Care Management

6.1 Cardiovascular Derangements, Myocardial Depression, and Hemodynamic Optimization 6.2 Acute Kidney Injury, Rhabdomyolysis / Myoglobinuria, and Fluid-Electrolyte Shifts 6.3 Gastrointestinal Complications, Ileus, Early Enteral Nutrition, and Curling's Ulcer Prophylaxis 6.4 Neurological Impairment, Anemia of Burn Injury, Coagulopathy, and Musculoskeletal Protection

7 Chapter 7: Hypermetabolism & Nutritional Support

7.1 The Biphasic Metabolic Response: Ebb vs. Flow Phases and Persistent Hypermetabolism 7.2 Indirect Calorimetry, Caloric Equations (Curreri/Toronto), and Micronutrient / Trace Mineral Needs 7.3 Pharmacological Modulation: Propranolol, Oxandrolone, Growth Hormone, and Exercise Therapy 7.4 Stress Hyperglycemia, Intensive Insulin Protocols, and Adrenal / Thyroid Axis Dysregulation

8 Chapter 8: Pain Management in Burn Care

8.1 Pain Classification in Burns: Background, Procedural, Breakthrough, and Chronic Neuropathic Pain 8.2 Multimodal Analgesia: Opioids, Ketamine, Gabapentinoids, NSAIDs, and Regional Anesthesia 8.3 Non-Pharmacological Modalities: Virtual Reality, Cognitive Behavioral Techniques, Hypnosis, and Distraction

9 Chapter 9: Agitation, Delirium & Post-Burn Pruritus

9.1 Agitation Management, Targeted Sedation Protocols (RASS/SAS), and Circadian Rhythm Support 9.2 ICU Delirium: Risk Factors, Screening (CAM-ICU/ICDSC), Non-Pharmacological Bundles, and Medical Management 9.3 Post-Burn Itch: Histaminergic vs. Neuropathic Pruritus, Oral Antihistamines, Gabapentin, and Topical Emollients

10 Chapter 10: Burn Wound Assessment, Topical Antimicrobials & Dressings

10.1 Serial Wound Bed Assessment, Tissue Perfusion, and Documentation Standards 10.2 Topical Antimicrobial Formulations: Silver Sulfadiazine, Mafenide Acetate, Silver Nitrate, and Modern Silver Dressings 10.3 Wound Bed Preparation: Surgical, Enzymatic (Collagenase/Bromelain), Autolytic, and Mechanical Debridement 10.4 Modern Dressings, Hydrogels, Foam Dressings, Negative Pressure Wound Therapy (NPWT), and Moisture Retentive Balances

11 Chapter 11: Surgical Excision, Skin Grafting & Wound Closure

11.1 Principles of Early Tangential vs. Fascial Surgical Excision and Blood Conservation 11.2 Split-Thickness and Full-Thickness Autografting: Mesh Expansion Ratios vs. Sheet Grafts 11.3 Biologic Coverings, Dermal Regeneration Templates (Integra/Novosorb BTM), Allograft, and Xenograft 11.4 Autologous Cell Suspensions (ReCell), Cultured Epithelial Autografts (CEA), and Donor Site Management

12 Chapter 12: Burn Sepsis, Infection Control & Antimicrobial Therapy

12.1 Burn Center Infection Control: Contact Precautions, Hydrotherapy Sanitation, and Environmental Controls 12.2 Differentiating Hypermetabolic SIRS from Burn Sepsis: ABA Consensus Sepsis Criteria 12.3 Common Burn Pathogens (Pseudomonas, MRSA, Acinetobacter, Candida, Aspergillus) and Empiric Coverage 12.4 Invasive Burn Wound Infection: Clinical Signs, Quantitative Biopsy (>10^5 CFU/g), and Histopathological Invasion

13 Chapter 13: Specific Burn Etiologies: Electrical, Chemical & Cold Injuries

13.1 Electrical Burn Injuries: High-Voltage vs. Low-Voltage, Arc/Flash, Cardiac Monitoring, and Deep Muscle Necrosis 13.2 Chemical Injuries: Acids (Coagulation Necrosis), Alkalis (Liquefactive Necrosis), Hydrofluoric Acid (Calcium Gluconate), and Decontamination 13.3 Radiation Burns, Cutaneous Radiation Syndrome, Cold Injuries (Frostbite Triage and Thawing Protocols), and Vasodilator Therapy

14 Chapter 14: Special Burn Populations & Cutaneous Syndromes

14.1 Pediatric Burn Resuscitation (Maintenance Fluids + D5W), Surface Area Dynamics, and Non-Accidental Trauma Screening 14.2 Geriatric Burn Care: Thin Dermis, Altered Fluid Tolerance, Pre-existing Comorbidities, and Mortality Prognostication (Baux Score) 14.3 Burn Injury in Pregnancy: Maternal Physiology, Resuscitation, and Fetal Surveillance 14.4 Severe Cutaneous Adverse Reactions: Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), SCORTEN, and Specialized Burn Unit Nursing 14.5 Necrotizing Soft Tissue Infections and Friction/Shear Injuries

15 Chapter 15: Rehabilitation, Scar Management & Reconstruction

15.1 Anti-Deformity Positioning, Range-of-Motion Exercises, and Custom Splinting Across Major Joints 15.2 Hypertrophic Scarring Mechanisms, Myofibroblasts, and Vancouver Scar Scale (VSS) Assessment 15.3 Custom Pressure Garments (20-30 mmHg), Silicone Sheeting, Fractional CO2 Laser Resurfacing, and Contracture Release 15.4 Psychosocial Recovery, Post-Traumatic Stress Disorder (PTSD), Body Image Adaptation, Peer Support (Phoenix Society), and School/Work Reintegration 15.5 Discharge Teaching, Transition to Ambulatory Care, and Home Management

16 Chapter 16: Professional Practice, Ethics, Quality & Disaster Triage

16.1 Ethical Dilemmas in Burn Critical Care, Surrogate Decision-Making, Futility, and Palliative / End-of-Life Symptom Management 16.2 Interprofessional Burn Team Roles, Multidisciplinary Rounds, Structured Handoffs, and Patient/Family Advocacy 16.3 Burn Quality Improvement, American Burn Association (ABA) Verification Standards, and National Burn Repository (NBR) Benchmarking 16.4 Diversity, Equity, Inclusion, and Intraprofessional Nursing Development 16.5 Community Outreach, Burn Prevention Education, and Home Safety 16.6 Mass Casualty Burn Disasters, Secondary Triage Schemes (ABA/ABLS Triage Matrix), Surge Capacity, and CBRN/HAZMAT Emergency Response

6.2 Acute Kidney Injury, Rhabdomyolysis / Myoglobinuria, and Fluid-Electrolyte Shifts

Key Takeaways Explain This Topic AI

Burn-associated acute kidney injury (AKI) displays a distinct biphasic etiology: Early AKI (<48 hours) stems from severe hypovolemic prerenal hypoperfusion, microthrombi, or obstructive pigment nephropathy, whereas Late AKI (>48 hours) is driven by hypermetabolic SIRS, burn sepsis, and cumulative nephrotoxic medications (aminoglycosides, vancomycin, colistin, IV contrast).

Fluid and electrolyte dynamics undergo dramatic, phase-specific transformations: initial hyponatremia and hyperkalemia (first 24–48 hours) from thermal cellular lysis transition during the post-resuscitation flow phase into profound hypokalemia, hypomagnesemia, hypophosphatemia (refeeding syndrome risk), and late hypernatremia driven by massive open-wound evaporative water loss.

Succinylcholine is absolutely contraindicated in burn patients beginning 24 to 48 hours post-injury and extending up to 1 to 2 years post-burn due to massive extrajunctional nicotinic acetylcholine receptor upregulation across skeletal muscle membranes, which triggers catastrophic, refractory hyperkalemic cardiac arrest.

Rhabdomyolysis and myoglobinuria are frequent, severe complications of high-voltage electrical trauma, crush injuries, and deep circumferential burns; free myoglobin precipitates in renal tubules under acidic conditions (forming obstructive ferrihemate casts) and exerts direct cytotoxic and vasoconstrictive damage on tubular epithelium.

The standard clinical protocol for pigmenturia mandates: (1) immediately increasing crystalloid resuscitation to maintain an adult urine output of 75–100 mL/hr (1.5–2.0 mL/kg/hr in pediatric patients) until macroscopic clearing, (2) urinary alkalinization with sodium bicarbonate to achieve a urine pH > 6.5, and (3) judicious administration of mannitol only after euvolemia has been confirmed.

Last updated: August 2026

6.2 Acute Kidney Injury, Rhabdomyolysis / Myoglobinuria, and Fluid-Electrolyte Shifts

Core Knowledge: Renal failure in major burn trauma carries a mortality rate exceeding 50% to 80%. Protecting renal function requires continuous surveillance of glomerular filtration, rapid identification of pigmenturia in high-voltage electrical and deep thermal injuries, aggressive titration of hourly urine output endpoints, and meticulous correction of dynamic electrolyte shifts. A specialized understanding of early versus late Acute Kidney Injury (AKI) and drug contraindications (particularly succinylcholine) is essential for CBRN practice.

1. Biphasic Pathophysiology of Burn Acute Kidney Injury (AKI)

Acute kidney injury in burn patients occurs in two distinct clinical phases, each governed by unique pathophysiological mechanisms: BIPHASIC SPECTRUM OF BURN ACUTE KIDNEY INJURY

  • ┌────────────────────────────────────────┬────────────────────────────────────────┐
  • │ EARLY AKI (<48 Hours) │ LATE AKI (>48 Hours) │
  • ├────────────────────────────────────────┼────────────────────────────────────────┤
  • │ • Primary Mechanism: Prerenal Ischemia │ • Primary Mechanism: Sepsis & Toxins │
  • │ • Intravascular hypovolemia & low CO │ • Septic acute tubular necrosis (ATN) │
  • │ • Angiotensin II & Vasopressin spasm │ • Hypermetabolic cytokine storm (TNF-α)│
  • │ • Renal cortical vasoconstriction │ • Nephrotoxic antimicrobials: │
  • │ • Intravascular hemolysis / Myoglobin │ Aminoglycosides, Vancomycin, Colistin│
  • │ • Microvascular fibrin thrombi deposit │ • Systemic endotoxemia & MODS │
  • │ • Progression: Ischemic ATN if delayed │ • Fluid overload / Creep complications │
  • └────────────────────────────────────────┴────────────────────────────────────────┘
  • Early AKI Pathogenesis (<48 Hours)

Early AKI develops as a direct consequence of burn shock. Intense sympathetic stimulation releases high levels of catecholamines, angiotensin II, aldosterone, and endothelin-1, triggering profound afferent arteriolar vasoconstriction in the renal cortex. Glomerular filtration rate (GFR) plummets. If intravascular volume is not restored rapidly with crystalloid resuscitation, prolonged prerenal ischemia leads directly to ischemic Acute Tubular Necrosis (ATN) characterized by tubular cell sloughing, granular cast formation, and loss of tubular concentrating ability.

Late AKI Pathogenesis (>48 Hours)

Late AKI occurs after initial resuscitation has been completed and is primarily driven by systemic sepsis, hyperinflammatory SIRS, and cumulative nephrotoxic insults :

Septic Vasodilation & Microvascular Shunting: Bacterial endotoxins and inflammatory cytokines induce renal microvascular shunting and bioenergetic tubular shutdown.

Nephrotoxic Antimicrobials: Burn intensive care frequently requires broad-spectrum empiric and targeted antibiotics (e.g., vancomycin, tobramycin, amikacin, polymyxin B, colistin) to combat multidrug-resistant pathogens ( Pseudomonas , Acinetobacter , MRSA). Drug accumulation rapidly induces direct tubular toxicity.

IV Contrast & Surgical Insults: Repeated CT imaging with iodinated contrast and periods of intraoperative hypotension during extensive burn excision exacerbate tubular injury.

2. Rhabdomyolysis, Myoglobinuria, and Pigment Nephropathy

Rhabdomyolysis occurs when damaged striated skeletal muscle releases intracellular contents—specifically myoglobin , potassium, creatine kinase (CK), and phosphate—into the systemic circulation. It is most frequently encountered in:

High-voltage electrical injuries ( ≥ 1 , 000 Volts \ge 1,000\text{ Volts} ≥ 1 , 000 Volts ) where deep muscular current passage causes massive electrothermal coagulation necrosis.

Crush injuries associated with structural collapse or blast trauma.

Deep, circumferential full-thickness extremity burns causing unreleased compartment syndrome. PATHOGENESIS OF PIGMENT NEPHROPATHY

  • ┌────────────────────────────────────────────────────────────────────────────────────────┐
  • │ Massive Electrothermal / Deep Muscle Necrosis ──► Systemic Release of Free Myoglobin │
  • │ │ │
  • │ ▼ │
  • │ Unbound Myoglobin Exceeds Plasma Haptoglobin Binding Capacity & Passes Glomerulus │
  • │ │ │
  • │ ▼ │
  • │ Under Acidic Tubular Conditions (pH < 5.6): Myoglobin Precipitates with Tamm-Horsfall │
  • │ Protein ──► Forms Obstructive Pigmented Ferrihemate / Uromodulin Casts in Distal Tubule│
  • │ │ │
  • │ ▼ │
  • │ Direct Cytotoxicity: Ferrihemate Generates Toxic Free Radicals & Lipid Peroxidation │
  • │ │ │
  • │ ▼ │
  • │ Myoglobin Scavenges Endogenous Nitric Oxide ──► Severe Intrarenal Vasoconstriction │
  • │ │ │
  • │ ▼ │
  • │ ACUTE OLIGURIC / ANURIC RENAL PIGMENTARY FAILURE (ATN) │
  • └────────────────────────────────────────────────────────────────────────────────────────┘
  • Clinical Presentation and Urine Screening

Visual Inspection: Urine displays a classic dark, port-wine, reddish-brown, or "tea-colored" appearance.

Urinalysis Discrepancy: Dipstick testing is strongly positive for "blood" (due to myoglobin's heme moiety), but microscopic examination reveals few or no intact red blood cells (0–2 RBCs/HPF).

Serum Biomarkers: Serum Creatine Kinase (CK) levels are markedly elevated (often > 10 , 000 >10,000 > 10 , 000 to > 100 , 000 U/L >100,000\text{ U/L} > 100 , 000 U/L ). Serum myoglobin is elevated.

Specialized Resuscitation Protocol for Pigmenturia

When macroscopic pigmenturia is observed, standard fluid formulas (Parkland/Brooke) are immediately superseded by the ABA Pigmenturia Resuscitation Protocol :

Intervention Target / Dosing Mechanism & Clinical Rationale

1. Increase Crystalloid Resuscitation Adults: 75–100 mL/hr; Pediatrics: 1.5–2.0 mL/kg/hr Flushes tubular lumen, prevents cast precipitation, and dilutes toxic pigment concentrations. Maintained until urine clears macroscopically.

2. Urinary Alkalinization Add 50 mEq Sodium Bicarbonate ( N a H C O 3 NaHCO_3 N a H C O 3 ​ ) per liter of IV fluid (e.g., D 5 W D_5W D 5 ​ W or 0.45% NS) Alkalinizes urine to target urine pH > 6.5 . Prevents dissociation of myoglobin into toxic ferrihemate and inhibits cast formation.

3. Osmotic Diuresis (Mannitol) 12.5 to 25 g IV bolus , repeated cautiously (max 100 g/day) Induces osmotic diuresis, flushes obstructing tubular casts, and scavenges hydroxyl radicals. Administer only AFTER intravascular volume is fully restored.

Warning

Never administer loop diuretics (furosemide) or mannitol to an unresuscitated, hypovolemic patient with pigmenturia. Furosemide acidifies tubular fluid, which accelerates myoglobin precipitation, and causes acute volume depletion that worsens renal ischemia.

3. Dynamic Fluid and Electrolyte Shifts Across Burn Phases

Burn trauma causes some of the most extreme electrolyte fluctuations in clinical medicine. Management requires distinguishing between the Resuscitation Phase (0–48 hours) and the Post-Resuscitation / Flow Phase (Days 3 to 14+) . ELECTROLYTE EVOLUTION ACROSS THE BURN CARE SPECTRUM

  • ┌──────────────┬────────────────────────────────────┬────────────────────────────────────┐
  • │ Electrolyte │ Resuscitation Phase (0–48 Hours) │ Flow / Recovery Phase (Days 3–14+) │
  • ├──────────────┼────────────────────────────────────┼────────────────────────────────────┤
  • │ Sodium │ HYPONATREMIA │ HYPERNATREMIA │
  • │ (Na+) │ Third-space shift; massive loss │ Massive evaporative free-water │
  • │ │ through open blisters and LR fluid │ loss through open wounds (L/day) │
  • ├──────────────┼────────────────────────────────────┼────────────────────────────────────┤
  • │ Potassium │ HYPERKALEMIA │ HYPOKALEMIA │
  • │ (K+) │ Thermal cellular lysis; tissue │ Hypermetabolic urinary wasting; │
  • │ │ necrosis; acidosis; prerenal GFR │ aldosterone; refeeding shift │
  • ├──────────────┼────────────────────────────────────┼────────────────────────────────────┤
  • │ Phosphate │ Variable / Mild elevation │ PROFOUND HYPOPHOSPHATEMIA │
  • │ (PO4 3-) │ Cellular release │ Refeeding; ATP synthesis; glycolysis│
  • ├──────────────┼────────────────────────────────────┼────────────────────────────────────┤
  • │ Calcium │ HYPOCALCEMIA │ HYPOCALCEMIA │
  • │ (Ca2+) │ Albumin loss (decreased total Ca); │ Must monitor Ionized Calcium (iCa);│
  • │ │ citrate toxicity from blood │ hypoparathyroidism of trauma │
  • ├──────────────┼────────────────────────────────────┼────────────────────────────────────┤
  • │ Magnesium │ Normal to slightly elevated │ HYPOMAGNESEMIA │
  • │ (Mg2+) │ Initial tissue release │ Renal wasting & wound exudate loss │
  • └──────────────┴────────────────────────────────────┴────────────────────────────────────┘
  • Sodium Dynamics

Early Hyponatremia ( N a + < 135 mEq/L Na^+ < 135\text{ mEq/L} N a + < 135 mEq/L ): Driven by massive shift of sodium into the intracellular compartment (sodium-potassium pump failure), exudative blister fluid loss, and dilution from massive crystalloid resuscitation.

Late Hypernatremia ( N a + > 145 – 150 mEq/L Na^+ > 145–150\text{ mEq/L} N a + > 145–150 mEq/L ): The loss of the epidermal stratum corneum allows pure free water to evaporate at rates of 3,000 to 5,000 mL/day . If insensible free-water losses are not matched with enteral free water or IV D 5 W D_5W D 5 ​ W , severe hyperosmolar hypernatremic dehydration results, causing cerebral shrinkage and intracranial hemorrhage.

Potassium Dynamics & The Succinylcholine Contraindication

Early Hyperkalemia ( K + > 5.5 mEq/L K^+ > 5.5\text{ mEq/L} K + > 5.5 mEq/L ): Direct thermal destruction of trillions of cell membranes dumps intracellular potassium into the extracellular space, compounded by metabolic acidosis.

Late Hypokalemia ( K + < 3.5 mEq/L K^+ < 3.5\text{ mEq/L} K + < 3.5 mEq/L ): Hypermetabolic cortisol and aldosterone release stimulates excessive renal potassium excretion in exchange for sodium. Intracellular uptake during enteral refeeding further depletes serum potassium, requiring aggressive potassium supplementation. THE SUCCINYLCHOLINE HYPERKALEMIC LETHAL CASCADE

  • ┌────────────────────────────────────────────────────────────────────────────────────────┐
  • │ Thermal Burn Trauma / Skeletal Muscle Denervation / Severe Systemic Inflammation │
  • │ │ │
  • │ ▼ │
  • │ Massive Proliferation & Spread of Extrajunctional Acetylcholine Receptors │
  • │ (Alpha-7 and Gamma Subunits) Across the ENTIRE Skeletal Muscle Sarcolemma │
  • │ │ │
  • │ ▼ │
  • │ Succinylcholine Administered (Depolarizing Neuromuscular Blocker) │
  • │ │ │
  • │ ▼ │
  • │ Prolonged Depolarization of Billions of Upregulated Extrajunctional ACh Receptors │
  • │ │ │
  • │ ▼ │
  • │ Massive, Uncontrollable Efflux of Intracellular Potassium into the Extracellular Space│
  • │ │ │
  • │ ▼ │
  • │ Serum Potassium Spikes by +5 to +10 mEq/L Within Minutes (Serum K+ > 8–10 mEq/L) │
  • │ │ │
  • │ ▼ │
  • │ PEAKED T-WAVES ──► WIDE QRS ──► SINE WAVE ──► VENTRICULAR FIBRILLATION / ASYSTOLE │
  • └────────────────────────────────────────────────────────────────────────────────────────┘

Caution

Succinylcholine is strictly contraindicated starting 24 to 48 hours after burn injury and remains contraindicated for at least 1 to 2 years post-burn (or until full rehabilitation and muscle restoration). For rapid sequence intubation (RSI), always utilize non-depolarizing neuromuscular blockers, such as rocuronium or vecuronium (reversal with sugammadex if necessary).

Calcium, Magnesium, and Phosphate Dynamics

Hypocalcemia: Total serum calcium drops due to profound hypoalbuminemia (calcium binds to albumin). Clinicians must monitor Ionized Calcium ( i C a iCa i C a ) (target 1.15 – 1.30 mmol/L 1.15–1.30\text{ mmol/L} 1.15–1.30 mmol/L ). Hypocalcemia impairs cardiac contractility and blunts coagulation factor cascades.

Hypophosphatemia ( P O 4 3 − < 2.5 mg/dL PO_4^{3-} < 2.5\text{ mg/dL} P O 4 3 − ​ < 2.5 mg/dL ): During the hypermetabolic flow phase and initiation of enteral nutrition, rapid cellular carbohydrate metabolism consumes inorganic phosphate for ATP and 2,3-DPG synthesis. Severe hypophosphatemia ( < 1.0 mg/dL <1.0\text{ mg/dL} < 1.0 mg/dL ) induces respiratory muscle failure (failure to wean from mechanical ventilation), diaphragmatic weakness, myocardial depression, and hemolytic anemia.

Hypomagnesemia ( M g 2 + < 1.7 mg/dL Mg^{2+} < 1.7\text{ mg/dL} M g 2 + < 1.7 mg/dL ): Excreted through wound exudate and aminoglycoside-induced tubular wasting. Must be corrected to prevent refractory hypokalemia and ventricular dysrhythmias (Torsades de Pointes).

4. Continuous Renal Replacement Therapy (CRRT) in Burns

When medical management fails to control AKI, Continuous Veno-Venous Hemodiafiltration (CVVHDF) or Hemofiltration (CVVH) is the modality of choice for hemodynamically unstable burn patients.

Burn-Specific CRRT Indications:

Refractory Uremic Encephalopathy or Pericarditis (BUN > 100 mg/dL >100\text{ mg/dL} > 100 mg/dL ).

Severe, Uncorrectable Hyperkalemia ( K + > 6.5 mEq/L K^+ > 6.5\text{ mEq/L} K + > 6.5 mEq/L with ECG changes).

Intractable Metabolic Acidosis ( pH < 7.15 \text{pH} < 7.15 pH < 7.15 , base deficit > 10 >10 > 10 ).

Volume Overload & Fluid Creep unresponsive to diuretics, threatening abdominal compartment syndrome or refractory gas exchange failure.

Cytokine Clearance / Adsorption: High-volume hemofiltration helps attenuate circulating inflammatory mediator peaks in severe septic shock.